Position
Associate Professor
Chair
Department of Pharmaceutical Sciences
Biography
PhD, Molecular Pharmacology, University of Wisconsin - Madison • MBA, University of Chicago, School of Business • BS, Pharmacy, University of Kansas • Postdoctoral Research Fellow, Laboratory of Gary J. Nabel, MD, PhD, Howard Hughes Medical Institute, Ann Arbor, MI • Joined LLU September 2004.
Research Interests
- Economic analysis of health-care policy in the United States
- Identification and implementation of strategies for global delivery of pharmaceutical care
Selected Publications
Mosavin, R. Post-transcriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Doctoral Dissertation, Archives, University of Wisconsin-Madison, 1996
Mosavin, R. and Mellon, W.S. Post-transcriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1,25-dihydroxyvitamin D3. Archives of Biochemistry and Biophysics 332(1):142-152, 1996
Felzien, L.K., Farrell, S., Betts, J.C., Mosavin, R., and Nabel, G.J. Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p200 coactivator. Mol. Cell. Biol. 19(6):4241-4246,1999
Sun, Y., Kolligs, F.T., Hottiger, M.O., Mosavin, R., Fearon, E.R., Nabel, G.J. Regulation of beta-catenin transformation by the p300 transcriptional coactivator. Proc Natl Acad Sci U S A. 97:(23):12613-8, 2000
Affiliations
Academy of Managed Care Pharmacy (AMCP)
American Association of Colleges of Pharmacy (AACP)
International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
Courses
RXSA 646 – Principles of Management
RXSA 743 – Health Systems, Reimbursement, and Pharmacoeconomics
RXSA 750 – Wall Street Journal
